326 related articles for article (PubMed ID: 8437123)
21. Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine.
Walker EA; Young AM
J Pharmacol Exp Ther; 1993 Oct; 267(1):322-30. PubMed ID: 8229759
[TBL] [Abstract][Full Text] [Related]
22. Discriminative stimulus properties of ketamine stereoisomers in phencyclidine-trained rats.
Brady KT; Balster RL
Pharmacol Biochem Behav; 1982 Aug; 17(2):291-5. PubMed ID: 7134239
[TBL] [Abstract][Full Text] [Related]
23. Phencyclidine-like discriminative stimulus effects of the stereoisomers of alpha- and beta-cyclazocine in rats.
Slifer BL; Balster RL
J Pharmacol Exp Ther; 1988 Feb; 244(2):606-12. PubMed ID: 3346838
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological analysis of the phencyclidine-like discriminative stimulus properties of narcotic derivatives in rats.
Shannon HE
J Pharmacol Exp Ther; 1982 Jul; 222(1):146-51. PubMed ID: 7086696
[TBL] [Abstract][Full Text] [Related]
25. Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization.
Colpaert FC; Janssen PA
J Pharmacol Exp Ther; 1984 Jul; 230(1):193-9. PubMed ID: 6747824
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological evaluation of N-allynormetazocine (SKF 10,047) on the basis of its discriminative stimulus properties in the rat.
Shannon HE
J Pharmacol Exp Ther; 1983 Apr; 225(1):144-52. PubMed ID: 6834266
[TBL] [Abstract][Full Text] [Related]
27. Discriminable effects of phencyclidine analogs evaluated by multiple drug (PCP versus OTHER) discrimination training.
Overton DA; Shen CF; Ke GY; Gazdick LP
Psychopharmacology (Berl); 1989; 97(4):514-20. PubMed ID: 2498947
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological specificity of the discriminative stimulus properties of 2-amino-4,5-(1,2-cyclohexyl)-7-phosphono-heptanoic acid (NPC 12626), a competitive N-methyl-D-aspartate receptor antagonist.
Bobelis DJ; Balster RL
J Pharmacol Exp Ther; 1993 Feb; 264(2):845-53. PubMed ID: 8437128
[TBL] [Abstract][Full Text] [Related]
29. N-methyl-D-aspartate receptors in associative eyeblink conditioning: both MK-801 and phencyclidine produce task- and dose-dependent impairments.
Thompson LT; Disterhoft JF
J Pharmacol Exp Ther; 1997 May; 281(2):928-40. PubMed ID: 9152403
[TBL] [Abstract][Full Text] [Related]
30. Phencyclidine established as a discriminative stimulus using ethanol as a reinforcer.
Beardsley PM; Anthony EW; Lopez OT
Behav Pharmacol; 1992 Oct; 3(5):497-505. PubMed ID: 11224152
[TBL] [Abstract][Full Text] [Related]
31. The role of GABAB receptors in the discriminative stimulus effects of gamma-hydroxybutyrate in rats: time course and antagonism studies.
Carter LP; Flores LR; Wu H; Chen W; Unzeitig AW; Coop A; France CP
J Pharmacol Exp Ther; 2003 May; 305(2):668-74. PubMed ID: 12606639
[TBL] [Abstract][Full Text] [Related]
32. Comparative electroencephalographic and behavioral effects of phencyclidine, (+)-SKF-10,047 and MK-801 in rats.
Marquis KL; Paquette NC; Gussio RP; Moreton JE
J Pharmacol Exp Ther; 1989 Dec; 251(3):1104-12. PubMed ID: 2557412
[TBL] [Abstract][Full Text] [Related]
33. Differential antagonism by naltrexone of the effects of opioids on a fixed-ratio discrimination in rats.
Moerschbaecher JM; Devia C; Brocklehurst C
J Pharmacol Exp Ther; 1988 Jan; 244(1):237-46. PubMed ID: 3336001
[TBL] [Abstract][Full Text] [Related]
34. MK-801 subsensitivity following postweaning lead exposure.
Cory-Slechta DA
Neurotoxicology; 1995; 16(1):83-95. PubMed ID: 7603648
[TBL] [Abstract][Full Text] [Related]
35. Effects of opioids in morphine-treated pigeons trained to discriminate among morphine, the low-efficacy agonist nalbuphine, and saline.
Walker EA; Picker MJ; Granger A; Dykstra LA
J Pharmacol Exp Ther; 2004 Jul; 310(1):150-8. PubMed ID: 15044559
[TBL] [Abstract][Full Text] [Related]
36. Involvement of adenosine A1 and A2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of cocaine and methamphetamine in rats.
Justinova Z; Ferre S; Segal PN; Antoniou K; Solinas M; Pappas LA; Highkin JL; Hockemeyer J; Munzar P; Goldberg SR
J Pharmacol Exp Ther; 2003 Dec; 307(3):977-86. PubMed ID: 14557381
[TBL] [Abstract][Full Text] [Related]
37. Tolerance and cross-tolerance to the discriminative stimulus properties of fentanyl and morphine.
Emmett-Oglesby MW; Shippenberg TS; Herz A
J Pharmacol Exp Ther; 1988 Apr; 245(1):17-23. PubMed ID: 3361440
[TBL] [Abstract][Full Text] [Related]
38. Structure-activity relationships of arylcyclohexylamines as discriminative stimuli in pigeons.
McMillan DE; Evans EB; Wessinger WD; Owens SM
J Pharmacol Exp Ther; 1988 Dec; 247(3):1086-92. PubMed ID: 2849658
[TBL] [Abstract][Full Text] [Related]
39. Discriminative stimulus properties of phencyclidine and five analogues in the squirrel monkey.
Brady KT; Balster RL
Pharmacol Biochem Behav; 1981 Feb; 14(2):213-8. PubMed ID: 7208560
[TBL] [Abstract][Full Text] [Related]
40. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
Picker MJ; Cook CD
Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
